- Why It Matters: The convergence of global leaders in Bangkok marks a significant step towards embracing medical cannabis in Asia, reflecting a shift in societal and regulatory perspectives.
- The Big Picture: The conference highlights the growing acceptance of cannabis for medical purposes, showcasing innovations and regulatory changes that pave the way for a sustainable cannabis industry in Asia.
- Zoom In: Discussions at the conference underscore the importance of creating impactful cannabis brands and the role of technology in advancing the medical cannabis market.
BANGKOK, THAILAND – The 3rd Annual Cannabis Business Asia Conference, held in Bangkok from February 29 to March 1, has become a beacon for the future of medical cannabis in Asia. This landmark event brought together world-class business leaders, scientists, and innovators, setting the stage for a discussion on the burgeoning potential of medical cannabis and hemp in the region.
DON LAND, administrator and executive chairman of Thai Cannabis Corporation, emphasized Thailand’s national sustainability plan, which includes cannabis as a key component. Meanwhile, DR. RICHARD NIXON GOMEZ from the Philippines shared insights into the country’s legislative efforts to legalize medical cannabis, highlighting a decade-long push towards acceptance.
The conference showcased technological advancements and regulatory shifts that are shaping the cannabis industry. From FYR Genetics’ breakthroughs in cannabis genetics to NuNature Labs’ exploration of prescription cannabis, the speakers highlighted the dynamic evolution of the market. Thailand’s progressive approach to cannabis regulation since 2019 was also a focal point, illustrating a significant shift towards a more open and regulated industry.
Creating impactful cannabis brands was another critical theme, with experts emphasizing the importance of consistent brand promises and the challenges of standing out in the competitive CBD sector. The conference also explored the integration of Eastern and Western business models, underscoring the global nature of the cannabis industry.
As the Cannabis Business Asia Conference concluded, the discussions and insights shared have laid the groundwork for a greener, more sustainable future in the Asian medical cannabis market. The collective wisdom of the attendees underscores the dynamic evolution of the industry, promising transformative impacts on healthcare, agriculture, and business strategies across Asia and beyond.
Original sources: Journal Online and BNN
